Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Arbitrary visuomotor mapping during object manipulation in Parkinson's disease

Identifieur interne : 001E08 ( Main/Corpus ); précédent : 001E07; suivant : 001E09

Arbitrary visuomotor mapping during object manipulation in Parkinson's disease

Auteurs : Dennis A. Nowak ; Mitra Ameli ; Friederike Kemper ; Anna-Sophia Sarfeld ; Djamel Bensmail ; Jürgen Konczak ; Gereon R. Fink

Source :

RBID : ISTEX:D60E8586DA620D06BF5FB2E159F73050E4BA3C69

English descriptors

Abstract

The objective of this study is to investigate whether subjects with Parkinson's disease are able to use arbitrary color cues linked to the mass of an object to be lifted allowing for the predictive selection of appropriate grip forces. Fourteen patients with Parkinson's disease used a precision grip to lift two objects of different masses (400 and 600 g) in random order. In a “no cue” condition, a noninformative neutral visual stimulus was presented before each lift, thereby not allowing any judgement about which mass to be lifted. In a “cue” condition an arbitrary color cue provided advance information about which of the two masses patients would have to lift in the subsequent trial. Patients performed the conditions with either hand and by both on and off drugs. In the “no cue” trials patients scaled the predictive grip force output according to the perceived mass of the preceding lift. In the “cue” experiment patients scaled grip force in a predictive manner to mass based on the provided color cues. The ability of arbitrary visuomotor mapping was evident at either hand and not influenced by medication on/off. The precision of arbitrary visuomotor mapping correlated negatively with age, but not with disease duration, severity of motor disability on and off drug, severity of cognitive impairment on and off drug, or the amount of levodopa equivalent daily dosage of dopaminergic drugs. These data imply that Parkinson's disease does not preclude the ability of visuomotor mapping in the grip‐lift task. © 2009 Movement Disorder Society

Url:
DOI: 10.1002/mds.22543

Links to Exploration step

ISTEX:D60E8586DA620D06BF5FB2E159F73050E4BA3C69

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
<author>
<name sortKey="Nowak, Dennis A" sort="Nowak, Dennis A" uniqKey="Nowak D" first="Dennis A." last="Nowak">Dennis A. Nowak</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ameli, Mitra" sort="Ameli, Mitra" uniqKey="Ameli M" first="Mitra" last="Ameli">Mitra Ameli</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kemper, Friederike" sort="Kemper, Friederike" uniqKey="Kemper F" first="Friederike" last="Kemper">Friederike Kemper</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sarfeld, Anna Ophia" sort="Sarfeld, Anna Ophia" uniqKey="Sarfeld A" first="Anna-Sophia" last="Sarfeld">Anna-Sophia Sarfeld</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bensmail, Djamel" sort="Bensmail, Djamel" uniqKey="Bensmail D" first="Djamel" last="Bensmail">Djamel Bensmail</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Physical Medicine and Rehabilitation, Hôpital R. Poincaré, Garches, AP‐HP, University of Versailles Saint‐Quentin, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Konczak, Jurgen" sort="Konczak, Jurgen" uniqKey="Konczak J" first="Jürgen" last="Konczak">Jürgen Konczak</name>
<affiliation>
<mods:affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fink, Gereon R" sort="Fink, Gereon R" uniqKey="Fink G" first="Gereon R." last="Fink">Gereon R. Fink</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D60E8586DA620D06BF5FB2E159F73050E4BA3C69</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22543</idno>
<idno type="url">https://api.istex.fr/document/D60E8586DA620D06BF5FB2E159F73050E4BA3C69/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001E08</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
<author>
<name sortKey="Nowak, Dennis A" sort="Nowak, Dennis A" uniqKey="Nowak D" first="Dennis A." last="Nowak">Dennis A. Nowak</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ameli, Mitra" sort="Ameli, Mitra" uniqKey="Ameli M" first="Mitra" last="Ameli">Mitra Ameli</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kemper, Friederike" sort="Kemper, Friederike" uniqKey="Kemper F" first="Friederike" last="Kemper">Friederike Kemper</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sarfeld, Anna Ophia" sort="Sarfeld, Anna Ophia" uniqKey="Sarfeld A" first="Anna-Sophia" last="Sarfeld">Anna-Sophia Sarfeld</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bensmail, Djamel" sort="Bensmail, Djamel" uniqKey="Bensmail D" first="Djamel" last="Bensmail">Djamel Bensmail</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Physical Medicine and Rehabilitation, Hôpital R. Poincaré, Garches, AP‐HP, University of Versailles Saint‐Quentin, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Konczak, Jurgen" sort="Konczak, Jurgen" uniqKey="Konczak J" first="Jürgen" last="Konczak">Jürgen Konczak</name>
<affiliation>
<mods:affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fink, Gereon R" sort="Fink, Gereon R" uniqKey="Fink G" first="Gereon R." last="Fink">Gereon R. Fink</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-10-15">2009-10-15</date>
<biblScope unit="volume">24</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="1925">1925</biblScope>
<biblScope unit="page" to="1933">1933</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D60E8586DA620D06BF5FB2E159F73050E4BA3C69</idno>
<idno type="DOI">10.1002/mds.22543</idno>
<idno type="ArticleID">MDS22543</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>basal ganglia</term>
<term>conditional motor learning</term>
<term>grip force</term>
<term>lift force</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objective of this study is to investigate whether subjects with Parkinson's disease are able to use arbitrary color cues linked to the mass of an object to be lifted allowing for the predictive selection of appropriate grip forces. Fourteen patients with Parkinson's disease used a precision grip to lift two objects of different masses (400 and 600 g) in random order. In a “no cue” condition, a noninformative neutral visual stimulus was presented before each lift, thereby not allowing any judgement about which mass to be lifted. In a “cue” condition an arbitrary color cue provided advance information about which of the two masses patients would have to lift in the subsequent trial. Patients performed the conditions with either hand and by both on and off drugs. In the “no cue” trials patients scaled the predictive grip force output according to the perceived mass of the preceding lift. In the “cue” experiment patients scaled grip force in a predictive manner to mass based on the provided color cues. The ability of arbitrary visuomotor mapping was evident at either hand and not influenced by medication on/off. The precision of arbitrary visuomotor mapping correlated negatively with age, but not with disease duration, severity of motor disability on and off drug, severity of cognitive impairment on and off drug, or the amount of levodopa equivalent daily dosage of dopaminergic drugs. These data imply that Parkinson's disease does not preclude the ability of visuomotor mapping in the grip‐lift task. © 2009 Movement Disorder Society</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Dennis A. Nowak MD, PhD</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
<json:string>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</json:string>
<json:string>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</json:string>
</affiliations>
</json:item>
<json:item>
<name>Mitra Ameli MD</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Friederike Kemper MD</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Anna‐Sophia Sarfeld MS</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Djamel Bensmail MD</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
<json:string>Department of Physical Medicine and Rehabilitation, Hôpital R. Poincaré, Garches, AP‐HP, University of Versailles Saint‐Quentin, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Jürgen Konczak MD, PhD</name>
<affiliations>
<json:string>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</json:string>
</affiliations>
</json:item>
<json:item>
<name>Gereon R. Fink MD, PhD</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
<json:string>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>grip force</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lift force</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>conditional motor learning</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>basal ganglia</value>
</json:item>
</subject>
<articleId>
<json:string>MDS22543</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>The objective of this study is to investigate whether subjects with Parkinson's disease are able to use arbitrary color cues linked to the mass of an object to be lifted allowing for the predictive selection of appropriate grip forces. Fourteen patients with Parkinson's disease used a precision grip to lift two objects of different masses (400 and 600 g) in random order. In a “no cue” condition, a noninformative neutral visual stimulus was presented before each lift, thereby not allowing any judgement about which mass to be lifted. In a “cue” condition an arbitrary color cue provided advance information about which of the two masses patients would have to lift in the subsequent trial. Patients performed the conditions with either hand and by both on and off drugs. In the “no cue” trials patients scaled the predictive grip force output according to the perceived mass of the preceding lift. In the “cue” experiment patients scaled grip force in a predictive manner to mass based on the provided color cues. The ability of arbitrary visuomotor mapping was evident at either hand and not influenced by medication on/off. The precision of arbitrary visuomotor mapping correlated negatively with age, but not with disease duration, severity of motor disability on and off drug, severity of cognitive impairment on and off drug, or the amount of levodopa equivalent daily dosage of dopaminergic drugs. These data imply that Parkinson's disease does not preclude the ability of visuomotor mapping in the grip‐lift task. © 2009 Movement Disorder Society</abstract>
<qualityIndicators>
<score>7.307</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>4</keywordCount>
<abstractCharCount>1557</abstractCharCount>
<pdfWordCount>4307</pdfWordCount>
<pdfCharCount>28865</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>251</abstractWordCount>
</qualityIndicators>
<title>Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>24</volume>
<publisherId>
<json:string>MDS</json:string>
</publisherId>
<pages>
<total>9</total>
<last>1933</last>
<first>1925</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>13</issue>
<subject>
<json:item>
<value>Research Article</value>
</json:item>
</subject>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2009</publicationDate>
<copyrightDate>2009</copyrightDate>
<doi>
<json:string>10.1002/mds.22543</json:string>
</doi>
<id>D60E8586DA620D06BF5FB2E159F73050E4BA3C69</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/D60E8586DA620D06BF5FB2E159F73050E4BA3C69/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/D60E8586DA620D06BF5FB2E159F73050E4BA3C69/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/D60E8586DA620D06BF5FB2E159F73050E4BA3C69/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2009</date>
</publicationStmt>
<notesStmt>
<note type="content">*Potential conflict of interest: None reported.</note>
<note>Deutsche Forschungsgemeinschaft - No. DFG NO737/4‐1;</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
<author>
<persName>
<forename type="first">Dennis A.</forename>
<surname>Nowak</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<note type="correspondence">
<p>Correspondence: Klinik Kipfenberg, Neurochirurgische und Neurologische Fachklinik, Kindinger Strasse 13, D‐85110 Kipfenberg, Germany</p>
</note>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</affiliation>
<affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</affiliation>
</author>
<author>
<persName>
<forename type="first">Mitra</forename>
<surname>Ameli</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Friederike</forename>
<surname>Kemper</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Anna‐Sophia</forename>
<surname>Sarfeld</surname>
</persName>
<roleName type="degree">MS</roleName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Djamel</forename>
<surname>Bensmail</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Department of Physical Medicine and Rehabilitation, Hôpital R. Poincaré, Garches, AP‐HP, University of Versailles Saint‐Quentin, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Jürgen</forename>
<surname>Konczak</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</affiliation>
</author>
<author>
<persName>
<forename type="first">Gereon R.</forename>
<surname>Fink</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-10-15"></date>
<biblScope unit="volume">24</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="1925">1925</biblScope>
<biblScope unit="page" to="1933">1933</biblScope>
</imprint>
</monogr>
<idno type="istex">D60E8586DA620D06BF5FB2E159F73050E4BA3C69</idno>
<idno type="DOI">10.1002/mds.22543</idno>
<idno type="ArticleID">MDS22543</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2009</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>The objective of this study is to investigate whether subjects with Parkinson's disease are able to use arbitrary color cues linked to the mass of an object to be lifted allowing for the predictive selection of appropriate grip forces. Fourteen patients with Parkinson's disease used a precision grip to lift two objects of different masses (400 and 600 g) in random order. In a “no cue” condition, a noninformative neutral visual stimulus was presented before each lift, thereby not allowing any judgement about which mass to be lifted. In a “cue” condition an arbitrary color cue provided advance information about which of the two masses patients would have to lift in the subsequent trial. Patients performed the conditions with either hand and by both on and off drugs. In the “no cue” trials patients scaled the predictive grip force output according to the perceived mass of the preceding lift. In the “cue” experiment patients scaled grip force in a predictive manner to mass based on the provided color cues. The ability of arbitrary visuomotor mapping was evident at either hand and not influenced by medication on/off. The precision of arbitrary visuomotor mapping correlated negatively with age, but not with disease duration, severity of motor disability on and off drug, severity of cognitive impairment on and off drug, or the amount of levodopa equivalent daily dosage of dopaminergic drugs. These data imply that Parkinson's disease does not preclude the ability of visuomotor mapping in the grip‐lift task. © 2009 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>grip force</term>
</item>
<item>
<term>lift force</term>
</item>
<item>
<term>conditional motor learning</term>
</item>
<item>
<term>basal ganglia</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article category</head>
<item>
<term>Research Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2009-01-12">Received</change>
<change when="2009-02-23">Registration</change>
<change when="2009-10-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/D60E8586DA620D06BF5FB2E159F73050E4BA3C69/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="130">
<doi origin="wiley" registered="yes">10.1002/mds.v24:13</doi>
<numberingGroup>
<numbering type="journalVolume" number="24">24</numbering>
<numbering type="journalIssue">13</numbering>
</numberingGroup>
<coverDate startDate="2009-10-15">15 October 2009</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="7" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.22543</doi>
<idGroup>
<id type="unit" value="MDS22543"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="9"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Research Article</title>
<title type="tocHeading1">Research Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2009 Movement Disorder Society</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2009-01-12"></event>
<event type="manuscriptRevised" date="2009-02-17"></event>
<event type="manuscriptAccepted" date="2009-02-23"></event>
<event type="firstOnline" date="2009-07-30"></event>
<event type="publishedOnlineFinalForm" date="2009-10-21"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2009-07-30"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">1925</numbering>
<numbering type="pageLast">1933</numbering>
</numberingGroup>
<correspondenceTo>Klinik Kipfenberg, Neurochirurgische und Neurologische Fachklinik, Kindinger Strasse 13, D‐85110 Kipfenberg, Germany</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS22543.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="2"></count>
<count type="tableTotal" number="2"></count>
<count type="referenceTotal" number="32"></count>
<count type="wordTotal" number="6408"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Arbitrary visuomotor mapping during object manipulation in Parkinson's disease
<link href="#fn3"></link>
</title>
<title type="short" xml:lang="en">Arbitrary Visuomotor Mapping in Parkinson's Disease</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2 #af3" corresponding="yes">
<personName>
<givenNames>Dennis A.</givenNames>
<familyName>Nowak</familyName>
<degrees>MD, PhD</degrees>
</personName>
<contactDetails>
<email normalForm="ca@neurologie-kipfenberg.de">ca@neurologie‐kipfenberg.de</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Mitra</givenNames>
<familyName>Ameli</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Friederike</givenNames>
<familyName>Kemper</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Anna‐Sophia</givenNames>
<familyName>Sarfeld</familyName>
<degrees>MS</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af1 #af4">
<personName>
<givenNames>Djamel</givenNames>
<familyName>Bensmail</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Jürgen</givenNames>
<familyName>Konczak</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af1 #af2">
<personName>
<givenNames>Gereon R.</givenNames>
<familyName>Fink</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="DE" type="organization">
<unparsedAffiliation>Department of Neurology, University of Cologne, Cologne, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="DE" type="organization">
<unparsedAffiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="US" type="organization">
<unparsedAffiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="FR" type="organization">
<unparsedAffiliation>Department of Physical Medicine and Rehabilitation, Hôpital R. Poincaré, Garches, AP‐HP, University of Versailles Saint‐Quentin, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">grip force</keyword>
<keyword xml:id="kwd2">lift force</keyword>
<keyword xml:id="kwd3">conditional motor learning</keyword>
<keyword xml:id="kwd4">basal ganglia</keyword>
</keywordGroup>
<fundingInfo>
<fundingAgency>Deutsche Forschungsgemeinschaft</fundingAgency>
<fundingNumber>DFG NO737/4‐1</fundingNumber>
</fundingInfo>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>The objective of this study is to investigate whether subjects with Parkinson's disease are able to use arbitrary color cues linked to the mass of an object to be lifted allowing for the predictive selection of appropriate grip forces. Fourteen patients with Parkinson's disease used a precision grip to lift two objects of different masses (400 and 600 g) in random order. In a “no cue” condition, a noninformative neutral visual stimulus was presented before each lift, thereby not allowing any judgement about which mass to be lifted. In a “cue” condition an arbitrary color cue provided advance information about which of the two masses patients would have to lift in the subsequent trial. Patients performed the conditions with either hand and by both on and off drugs. In the “no cue” trials patients scaled the predictive grip force output according to the perceived mass of the preceding lift. In the “cue” experiment patients scaled grip force in a predictive manner to mass based on the provided color cues. The ability of arbitrary visuomotor mapping was evident at either hand and not influenced by medication on/off. The precision of arbitrary visuomotor mapping correlated negatively with age, but not with disease duration, severity of motor disability on and off drug, severity of cognitive impairment on and off drug, or the amount of levodopa equivalent daily dosage of dopaminergic drugs. These data imply that Parkinson's disease does not preclude the ability of visuomotor mapping in the grip‐lift task. © 2009 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn3">
<p>Potential conflict of interest: None reported.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Arbitrary Visuomotor Mapping in Parkinson's Disease</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Arbitrary visuomotor mapping during object manipulation in Parkinson's disease</title>
</titleInfo>
<name type="personal">
<namePart type="given">Dennis A.</namePart>
<namePart type="family">Nowak</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</affiliation>
<affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</affiliation>
<description>Correspondence: Klinik Kipfenberg, Neurochirurgische und Neurologische Fachklinik, Kindinger Strasse 13, D‐85110 Kipfenberg, Germany</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Mitra</namePart>
<namePart type="family">Ameli</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Friederike</namePart>
<namePart type="family">Kemper</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Anna‐Sophia</namePart>
<namePart type="family">Sarfeld</namePart>
<namePart type="termsOfAddress">MS</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Djamel</namePart>
<namePart type="family">Bensmail</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Department of Physical Medicine and Rehabilitation, Hôpital R. Poincaré, Garches, AP‐HP, University of Versailles Saint‐Quentin, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Jürgen</namePart>
<namePart type="family">Konczak</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Human Sensorimotor Control Laboratory, University of Minnesota, Minneapolis, Minnesota</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Gereon R.</namePart>
<namePart type="family">Fink</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Institute of Neuroscience and Medicine (INM‐3), Cognitive Neurology, Research Centre Jülich, Jülich, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2009-10-15</dateIssued>
<dateCaptured encoding="w3cdtf">2009-01-12</dateCaptured>
<dateValid encoding="w3cdtf">2009-02-23</dateValid>
<copyrightDate encoding="w3cdtf">2009</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">2</extent>
<extent unit="tables">2</extent>
<extent unit="references">32</extent>
<extent unit="words">6408</extent>
</physicalDescription>
<abstract lang="en">The objective of this study is to investigate whether subjects with Parkinson's disease are able to use arbitrary color cues linked to the mass of an object to be lifted allowing for the predictive selection of appropriate grip forces. Fourteen patients with Parkinson's disease used a precision grip to lift two objects of different masses (400 and 600 g) in random order. In a “no cue” condition, a noninformative neutral visual stimulus was presented before each lift, thereby not allowing any judgement about which mass to be lifted. In a “cue” condition an arbitrary color cue provided advance information about which of the two masses patients would have to lift in the subsequent trial. Patients performed the conditions with either hand and by both on and off drugs. In the “no cue” trials patients scaled the predictive grip force output according to the perceived mass of the preceding lift. In the “cue” experiment patients scaled grip force in a predictive manner to mass based on the provided color cues. The ability of arbitrary visuomotor mapping was evident at either hand and not influenced by medication on/off. The precision of arbitrary visuomotor mapping correlated negatively with age, but not with disease duration, severity of motor disability on and off drug, severity of cognitive impairment on and off drug, or the amount of levodopa equivalent daily dosage of dopaminergic drugs. These data imply that Parkinson's disease does not preclude the ability of visuomotor mapping in the grip‐lift task. © 2009 Movement Disorder Society</abstract>
<note type="content">*Potential conflict of interest: None reported.</note>
<note type="funding">Deutsche Forschungsgemeinschaft - No. DFG NO737/4‐1; </note>
<subject lang="en">
<genre>Keywords</genre>
<topic>grip force</topic>
<topic>lift force</topic>
<topic>conditional motor learning</topic>
<topic>basal ganglia</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<genre type="Journal">journal</genre>
<subject>
<genre>article category</genre>
<topic>Research Article</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2009</date>
<detail type="volume">
<caption>vol.</caption>
<number>24</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>13</number>
</detail>
<extent unit="pages">
<start>1925</start>
<end>1933</end>
<total>9</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">D60E8586DA620D06BF5FB2E159F73050E4BA3C69</identifier>
<identifier type="DOI">10.1002/mds.22543</identifier>
<identifier type="ArticleID">MDS22543</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2009 Movement Disorder Society</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E08 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001E08 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:D60E8586DA620D06BF5FB2E159F73050E4BA3C69
   |texte=   Arbitrary visuomotor mapping during object manipulation in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024